Dopavision Presented Key Data from its MyopiaX-1 Clinical Trial at the 19th International Myopia Conference
Dopavision Presented Key Data from its MyopiaX-1 Clinical Trial at the 19th International Myopia Conference — First Data Presentation: Friday’s presentation marked the first public disclosure of the 6-month data from the MyopiaX-1 clinical trial in children with myopia (NCT04967287). — MyopiaX Clinical Outcomes: MyopiaX demonstrated positive proof of concept at six months, showing promise […]